Our course content is comprehensive and is based on the RCP syllabus.
We urge you to be active in your learning, seeking the knowledge you need from most appropriate sources, rather than passively reading books from cover to cover. You need to decide what you need to learn (i.e. set objectives), decide where you will learn it from (select sources), and then learn. The detailed syllabus below provides you with list of topics you are expected to learn for your MRCP part II Written exam. We have aimed to cover almost all the items on this list in our course. We encourage you to use this list to structure your revision (whether you come to our course or not!).
Some of the downloads featured within this page require Acrobat Reader. If you require a free copy please click on the yellow Adobe icon on the right: 
Syllabus Item
Cardiology:
Cardiac investigations
Valvular disease/Endocarditis
Arrhythmias
Congenital heart disease
Ischaemic heart disease
Cardiac failure
Cardiomyopathy
Myocarditis
Rheumatic heart disease
Pericardial disease
Hypertension
Diseases of the large vessels
Drug metabolism/interactions investigations
Poisoning
Drugs for specific conditions
Drugs during pregnancy/breast feeding
Drug prescribing in liver/renal failure
Specific adverse effects
Endocrinology and metabolic medicine:
Hormone physiology/action
Diabetes mellitus/hypoglycaemia
Obesity
The pituitary gland/disease
The thyroid gland
Adrenal disease/endocrine hypertension
Parathyroid disease
Puberty/growth
Sodium/water balance
Endocrine syndromes
Reproductive endocrinology
Lipid metabolism
GI investigations
Liver diseases
Inflammatory bowel disease
Small bowel disorders
Irritable bowel syndrome
Oseophageal disease
Gastric disorders
Pancreatitis/pancreas carcinoma
GI tract carcinomas
Carcinoid tumours
Gonorrhoea
Syphilis
Chlamydia infections
HIV/AIDS
Theories of aging
Specific features of disease in the elderly
Prescribing for the elderly
Falls
Nutrition
Rehabilitation
Community care
Host/organism interaction
Common microbes/drugs
Respiratory infections
Gastrointestinal infections
Neurological infections
Musculoskeletal infections
Post-splenectomy infections
Pyrexia of unknown origin
Tuberculosis
Malaria
Other specific infections
Genetics of cancer
Specific cancers
Paraneoplastic syndromes
Oncological emergencies
Cancer therapy
Aims
Symptom control
Psychological support
MDT support
Role of religion
Anatomy and Definitions
Causes
Risk factors
Investigations
Management
Complications
Prognosis
Cranial nerves and the eye
Dysthyroid eye disease
Diabetes
Connective tissue disease
Uveitis
Other systemic disease
Degenerative disease
Optic atrophy
Tropical disease
Advances in treatment of ophthalmological disease
Imaging
EEG disease/Endocarditis
EMG
Classical cranial nerve signs
Intracranial haemorrhage
Epilepsy
Parkinson’s disease
Non-parkinsonian movement disorders
Demyelinating disease
Meningitis & encephalitis
AIDS and the CNS
Raised intracranial pressure
Headache
Spinal cord disease
Motor neurone and degenerative disease
Dementia
Neuroectodermal syndromes
Inherited neuropathies
Peripheral nerve disease
Metabolic and toxic neuropathies
Neuromuscular junction disease
Paraneoplastic syndromes
Muscular dystrophies
Myotonias
Metabolic myopathies
Suicide and deliberate self harm
Advances in treatment of neurological disease
Eczema
Psoriasis
Sebhorroeic dermatitis
Lichen Planus
Urticaria
Hereditary angio-oedema
Erythema nodosum
Bullous disease
Bacterial Infections
Viral infections
Fungal infections
Cutaneous manifestations of rheumatological disease
Cutaneous manifestations of endocrinological disease
Drug reactions
Naevi and tumours
Disorders of pigmentation
Photosensitivity
Disorders of collagen and connective tissues
Advances in treatment of dermatology
Anaemia
Haemoglobinopathies
Sickle cell disease
Immune Haemolysis
Myeloproliferative disorders
Splenomegaly
Haemophilia
Other bleeding disorders
Prothrombotic disorders
Leukaemia
Lymphoma
Paraproteinaemias
Advances in treatment of haematological malignancy
Phagocyte deficiency
Complement deficiency
T cell deficiency
Antibody deficiency
Combined deficiencies
Hypersensivity
Advances in treatment of immunological disease
Glomerulonephritis
Nephritic syndrome
Renal failure
Dialysis
Renal aspects of systemic vasculitis & SLE
Renal aspects of other systemic disease
Diabetes
Hypertension
Cardiovascular disease
Interstitial nephritis
Calculi
Drugs
Advances in treatment of immunological disease
Pulmonary function tests
Imaging and diagnostics
COPD
Obstructive sleep apnoea
Bronchiectasis
Cystic fibrosis
Asthma
Pneumonias
Opportunistic infection
Tuberculosis
Granulomatous disease
The lung and connective tissue disease
Eosinophilia and vasculitic syndromes
Pulmonary fibrosis
Primary pulmonary hypertension
Occupational lung disease
Lung tumours
Pneumothorax
Advances in treatment of respiratory disease
Osteoarthritis
Rheumatoid arthritis
Drugs and rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthropathy
Other seronegative spondyloarthopathies
Stills disease
Infective arthritis
SLE
Systemic sclerosis
Antiphospholipid syndrome
Inflammatory muscle disease
Sjögren’s syndrome
Systemic vasculitis
Behcet’s disease
Crystal deposition disease
Arthritis in metabolic disease
Rare arthropathies
Paget’s disease
Parathyroid disease
Osteoporosisl
Osteomalacia
Collagen/connective tissue disorders
Advances in treatment of rheumatological disease
Chromosomal disorders
Mitochondrial disorders
Single gene defects
Tumour suppressor genes
Gene therapy
HLA associations failure
Advances in clinical genetics
|
